Bumetanide for neonatal seizures: Based on evidence or enthusiasm?
Sampsa Vanhatalo,
Lena Hellström-Westas,
Linda S. De Vries,
Sampsa Vanhatalo
Department of Children’s Clinical Neurophysiology, Helsinki University Central Hospital, Helsinki, Finland [email protected]
Search for more papers by this authorLena Hellström-Westas
Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
Search for more papers by this authorLinda S. De Vries
Department of Neonatology, Wilhelmina Children’s Hospital, UMC Utrecht, the Netherlands
Search for more papers by this authorSampsa Vanhatalo,
Lena Hellström-Westas,
Linda S. De Vries,
Sampsa Vanhatalo
Department of Children’s Clinical Neurophysiology, Helsinki University Central Hospital, Helsinki, Finland [email protected]
Search for more papers by this authorLena Hellström-Westas
Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden
Search for more papers by this authorLinda S. De Vries
Department of Neonatology, Wilhelmina Children’s Hospital, UMC Utrecht, the Netherlands
Search for more papers by this authorNo abstract is available for this article.
References
- Booth D, Evans DJ. (2004) Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev 4:CD004218.
- Dreier JP, Zhang CL, Heinemann U. (1998) Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. Acta Neurol Scand 98: 154–160.
- Dzhala VI, Talos DM, Sdrulla DA, Brumback AC, Mathews GC, Benke TA, Delpire E, Jensen FE, Staley KJ. (2005) NKCC1 transporter facilitates seizures in the developing brain. Nat Med 11: 1205–1213.
- Dzhala VI, Brumback AC, Staley KJ. (2008) Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 63: 222–235.
- Haglund MM, Hochman DW. (2005) Furosemide and mannitol suppression of epileptic activity in the human brain. J Neurophysiol 94: 907–918.
- Hochman DW, Baraban SC, Owens JW, Schwartzkroin PA. (1995) Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 270: 99–102.
- Huberfeld G, Wittner L, Clemenceau S, Baulac M, Kaila K, Miles R, Rivera C. (2007) Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27: 9866–9873.
- Kilb W, Sinning A, Luhmann HJ. (2007) Model-specific effects of bumetanide on epileptiform activity in the in-vitro intact hippocampus of the newborn mouse. Neuropharmacology 53: 524–533.
- Owens DF, Kriegstein AR. (2002) Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3: 715–727.
- Pallas SL. (2001) Intrinsic and extrinsic factors that shape neocortical specification. Trends Neurosci 24: 417–423.
- Rheims S, Represa A, Ben-Ari Y, Zilberter Y. (2008) Layer specific generation and propagation of seizures in slices of developing neocortex: role of excitatory GABAergic synapses. J Neurophysiol 100: 620–628.
- Silverstein FS, Jensen FE, Inder T, Hellstrom-Westas L, Hirtz D, Ferriero DM. (2008) Improving the treatment of neonatal seizures: national institute of neurological disorders and stroke workshop report. J Pediatr 153: 12–15.
- Sipilä ST, Schuchmann S, Voipio J, Yamada J, Kaila K. (2006) The cation-chloride cotransporter NKCC1 promotes sharp waves in the neonatal rat hippocampus. J Physiol 573: 765–773.
-
Yamada J,
Okabe A,
Toyoda H,
Kilb W,
Luhmann HJ,
Fukuda A. (2004) Cl− uptake promoting depolarizing GABA actions in immature rat neocortical neurones is mediated by NKCC1.
J Physiol
557(Pt 3): 829–841.
10.1113/jphysiol.2004.062471 Google Scholar